Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.7.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
CURRENT ASSETS    
Cash and cash equivalents $ 9,664 $ 9,502
Accounts receivable, net of allowance for doubtful accounts 12,675 11,748
Other current assets 2,018 2,174
Total current assets 24,357 23,424
FIXED ASSETS, net of accumulated depreciation 4,778 4,738
OTHER ASSETS    
Restricted cash 300 300
Patents and other intangible assets, net of accumulated amortization 1,451 1,503
Investment in joint venture 256 268
Goodwill 12,029 12,029
Other 194 172
Total other assets 14,230 14,272
Total Assets 43,365 42,434
CURRENT LIABILITIES    
Accounts payable and accrued expenses 8,099 8,148
Obligations under capital leases, current portion 229 109
Deferred revenue 432 789
Term note, current portion 0 2,000
Total current liabilities 8,760 11,046
Term note 4,779 2,654
Obligations under capital leases 616 374
Deferred rent payable and other 229 290
Warrant liability 7,620 2,018
Deferred revenue, long-term 436 428
Total Liabilities 22,440 16,810
STOCKHOLDERS’ EQUITY    
Preferred stock, authorized 9,764 shares, $0.0001 par value, none issued 0 0
Common stock, authorized 100,000 shares, $0.0001 par value, 19,756 and 18,936 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively 2 2
Additional paid-in capital 144,457 139,576
Accumulated (deficit) (123,534) (113,954)
Total Stockholders’ Equity 20,925 25,624
Total Liabilities and Stockholders’ Equity $ 43,365 $ 42,434